This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,566,446,070 units of the BOOSTRIX TDAP vaccine syringe (0.5 ml). The firm-fixed-price contract is valued at $1,053.96 and has an ultimate completion date of November 18, 2024. The contract is not designated as a set-aside. AmerisourceBergen, a for-profit organization registered in the System for Award Management (SAM.gov), holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as the primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Generated 2/14/25, 9:33 AM